Brief: Noxopharm Ltd Says Scaling Up Production Of Its Preclinical SOF-SKN Lupus Medication
14/05/2024 02:47
May 14 (Reuters) - Noxopharm Ltd NOX.AX :
* SCALING UP PRODUCTION OF ITS PRECLINICAL SOF-SKN LUPUS
MEDICATION
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer